Helix Biopharma : Announces Extension of Early Warrant Exerc

RICHMOND, ON / ACCESSWIRE / April 13, 2022 / Helix BioPharma Corp. , a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its... | April 13, 2022

Related Keywords

Canada , Toronto , Ontario , Richmond Hill , Canadian , Frank Michalargias , Toronto Stock Exchange , Helix Biopharma Corp , Incentive Program , Helix Biopharma , Early Warrant Exercise Incentive Program , Eligible Warrants , Incentive Exercise Price , Extended Warrants , Warrant Extension , Anne Mitchell , Grove Issuer Services , Jerzy Wilczewski , Chief Financial , Looking Statements , Helix Biopharma Corp Stock Exchange , News , Information , Press Release , N , Accesswire , Pril , 022 , Felix , Iopharma , Iopharmaceutical , Company , Developing , Unique , Therapies , The , Field , F , Ased , N Hbp Ca4229101098 ,